You just read:

BioLineRx Presents Preclinical Data at ASCO-SITC Showing BL-8040 Prolongs Survival by Mediating Tumor Infiltration of Antigen-Specific T-cells

News provided by

BioLineRx Ltd.

23 Jan, 2018, 13:00 GMT